Clinical Trials Directory

Trials / Unknown

UnknownNCT05699577

Prognostic Value of Some Biochemical Markers in Breast Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTserum sample for ELIZAELIZA for Ca15-3 and interferon gamma

Timeline

Start date
2023-02-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2023-01-26
Last updated
2023-01-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05699577. Inclusion in this directory is not an endorsement.